Analyze current and emerging clinical data on systemic therapies, including immunotherapies, targeted agents, antibody-drug conjugates, radioligand therapies, and PARP inhibitors across GI, GU, lung, and breast cancers.

Apply biomarker-driven and molecular diagnostic testing (e.g., HER2, RET, KRAS, BRAF, PI3K/Akt) to inform treatment selection and personalize therapy.

Evaluate the safety profiles, mechanisms of action, and efficacy outcomes of novel agents to support informed clinical decision-making and patient counseling.

Integrate evidence-based strategies for managing toxicities and optimizing sequencing of systemic therapies within multidisciplinary care frameworks.

Engage patients in shared decision-making by communicating current standards of care and the role of clinical trials in expanding treatment options.

Collaborate across the oncology care team to develop individualized treatment plans that consider tumor characteristics, patient preferences, and emerging research.